Exact Mass: 197.0452

Exact Mass Matches: 197.0452

Found 36 metabolites which its exact mass value is equals to given mass value 197.0452, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

2-Amino-5-phosphonopentanoic acid

2-Amino-5-phosphonopentanoic acid

C5H12NO5P (197.0453)


DL-AP5 (2-APV) is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist. DL-AP5 shows significantly antinociceptive activity. DL-AP5 specifically blocks on channels in the rabbit retina[1][2][3].

   

FR-900098

(3-(Acetylhydroxyamino)propyl)phosphonic acid

C5H12NO5P (197.0453)


   

vanillyl mandelate

2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)acetate

C9H9O5 (197.045)


Vanillyl mandelate, also known as 3-methoxy-4-hydroxymandelate or vanilmandelic acid, is a member of the class of compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. Vanillyl mandelate is soluble (in water) and a weakly acidic compound (based on its pKa). Vanillyl mandelate can be found in a number of food items such as brazil nut, feijoa, kiwi, and redcurrant, which makes vanillyl mandelate a potential biomarker for the consumption of these food products. Vanillylmandelic acid (VMA) is a chemical intermediate in the synthesis of artificial vanilla flavorings and is an end-stage metabolite of the catecholamines, epinephrine, and norepinephrine. It is produced via intermediary metabolites .

   

O-Acetyl-L-homoserine hydrochloride

O-Acetyl-L-homoserine hydrochloride

C6H12ClNO4 (197.0455)


   

N-methyl-L-glutamic acid

N-methyl-L-glutamic acid

C6H12ClNO4 (197.0455)


   

2-(Trifluoromethyl)quinoline

2-(Trifluoromethyl)quinoline

C10H6F3N (197.0452)


   

H-DL-Asp(OMe)-OMe.HCl

H-DL-Asp(OMe)-OMe.HCl

C6H12ClNO4 (197.0455)


   

D-AP5(mM/ml)

D-AP5(mM/ml)

C5H12NO5P (197.0453)


D-AP5 (D-APV) is a selective and competitive NMDA receptor antagonist with a Kd of 1.4 μM. D-AP5 (D-APV) inhibits the glutamate binding site of NMDA receptors[1][2].

   

(S)-2-AMINO-5-METHOXY-5-OXOPENTANOIC ACID HYDROCHLORIDE

(S)-2-AMINO-5-METHOXY-5-OXOPENTANOIC ACID HYDROCHLORIDE

C6H12ClNO4 (197.0455)


   

Sodium 1H-indol-3-ylacetate

Sodium 1H-indol-3-ylacetate

C10H8NNaO2 (197.0453)


   
   

H-D-Asp(OMe)-OMe.HCl

H-D-Asp(OMe)-OMe.HCl

C6H12ClNO4 (197.0455)


   

Glutamic acid,3-methyl-

Glutamic acid,3-methyl-

C6H12ClNO4 (197.0455)


   

8-(Trifluoromethyl)quinoline

8-(Trifluoromethyl)quinoline

C10H6F3N (197.0452)


   

6-(Trifluoromethyl)quinoline

6-(Trifluoromethyl)quinoline

C10H6F3N (197.0452)


   

Dimethyl iminodiacetate hydrochloride

Dimethyl iminodiacetate hydrochloride

C6H12ClNO4 (197.0455)


   

L-beta-Homoglutamic acid hydrochloride

L-beta-Homoglutamic acid hydrochloride

C6H12ClNO4 (197.0455)


   

(2S,4S)-4-METHYLGLUTAMIC ACID HYDROCHLORIDE

(2S,4S)-4-METHYLGLUTAMIC ACID HYDROCHLORIDE

C6H12ClNO4 (197.0455)


   

3-(Trifluoromethyl)quinoline

3-(Trifluoromethyl)quinoline

C10H6F3N (197.0452)


   

H-Asp(OMe)-OMe.HCl

H-Asp(OMe)-OMe.HCl

C6H12ClNO4 (197.0455)


   

5-(Trifluoromethyl)quinoline

5-(Trifluoromethyl)quinoline

C10H6F3N (197.0452)


   

3-(3,4-Dihydroxyphenyl)lactate

3-(3,4-Dihydroxyphenyl)lactate

C9H9O5- (197.045)


   

4-Hydroxy-3,5-dimethoxybenzoate

4-Hydroxy-3,5-dimethoxybenzoate

C9H9O5- (197.045)


   

(2R)-3-(3,4-dihydroxyphenyl)lactate

(2R)-3-(3,4-dihydroxyphenyl)lactate

C9H9O5- (197.045)


   

(3E)-3-[(1R,5R,6S)-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-ylidene]pyruvate

(3E)-3-[(1R,5R,6S)-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-ylidene]pyruvate

C9H9O5- (197.045)


A 2-oxo monocarboxylic acid anion that is the conjugate base of (3E)-3-[(1R,5R,6S)-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-ylidene]pyruvic acid, obtained by deprotonation of the carboxy group.

   

Vanillyl mandelate

Vanillyl mandelate

C9H9O5- (197.045)


   

(2S)-3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate

(2S)-3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate

C9H9O5- (197.045)


   

3-[(2Z,5R)-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-ylidene]-2-oxopropanoate

3-[(2Z,5R)-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-ylidene]-2-oxopropanoate

C9H9O5- (197.045)


   

2-Amino-4-hydroxy-4-[hydroxy(methyl)phosphoryl]butanoic acid

2-Amino-4-hydroxy-4-[hydroxy(methyl)phosphoryl]butanoic acid

C5H12NO5P (197.0453)


   

2-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)acetate

2-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)acetate

C9H9O5- (197.045)


   

Vanillylmandelate

Vanillylmandelate

C9H9O5- (197.045)


A hydroxy monocarboxylic acid anion that is the conjugate base of vanillylmandelic acid.

   

4,6-Dihydroxy-2-(hydroxymethyl)-3-methylbenzoate

4,6-Dihydroxy-2-(hydroxymethyl)-3-methylbenzoate

C9H9O5- (197.045)


   

(3-(Acetylhydroxyamino)propyl)phosphonic acid

(3-(Acetylhydroxyamino)propyl)phosphonic acid

C5H12NO5P (197.0453)


   

DL-AP5

2-Amino-5-phosphonopentanoic acid

C5H12NO5P (197.0453)


The 5-phosphono derivative of 2-aminopentanoic acid; acts as an N-methyl-D-aspartate receptor antagonist. DL-AP5 (2-APV) is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist. DL-AP5 shows significantly antinociceptive activity. DL-AP5 specifically blocks on channels in the rabbit retina[1][2][3].

   

Syringate

Syringate

C9H9O5 (197.045)


A methoxybenzoate that is the conjugate base of syringic acid, obtained by deprotonation of the carboxy group.

   

3-(n-hydroxyacetamido)propylphosphonic acid

3-(n-hydroxyacetamido)propylphosphonic acid

C5H12NO5P (197.0453)